HomeInsightsResults

Glenmark Life Sciences Ltd Quarterly Result

Glenmark Life Sciences Ltd Quarterly Result

stocks purchased

₹ 1.4 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

13.1 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Glenmark Life Sciences Ltd

NSE: GLS

Net Profit

₹ 95.32

Last updated on: Nov 25, 2024

Key Highlights

  • The revenue of Glenmark Life Sciences Ltd for the Sep '24 is ₹ 515.41 crore as compare to the Jun '24 revenue of ₹ 594.11 crore. This represent the decline of -13.246707%.
  • The ebitda of Glenmark Life Sciences Ltd for the Sep '24 is ₹ 142.89 crore as compare to the Jun '24 ebitda of ₹ 164.98 crore. This represent the decline of -13.389499%.
  • The net profit of Glenmark Life Sciences Ltd for the Sep '24 is ₹ 95.32 crore as compare to the Jun '24 net profit of ₹ 111.48 crore. This represent the decline of -14.495876%.

Results Analysis

Market Price of Glenmark Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Nov 20241093.25
22 Nov 20241048.9
21 Nov 20241081.15
19 Nov 20241084
18 Nov 20241082.05
14 Nov 20241080.35
13 Nov 20241060.65
12 Nov 20241096.1
11 Nov 20241091.1
08 Nov 20241094.65

Historical Revenue of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Glenmark Life Sciences Ltd News Hub

News

Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2

Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 Septe...

Read more

25 Oct 202412:45

News

Glenmark Life Sciences announces board meeting date

Glenmark Life Sciences will hold a meeting of the Board of Directors of the Company on 24 ...

Read more

17 Oct 202417:07

News

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will...

Read more

06 Sep 202416:35

News

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are amo...

Read more

05 Aug 202412:00

News

Glenmark Life drops after Q1 PAT slides 18% YoY to Rs 111 cr

Revenue from operations rose 1.75% YoY to Rs 588.62 crore in the first quarter of FY25. Pr...

Read more

26 Jul 202412:21

News

Glenmark Life Sciences to hold board meeting

Glenmark Life Sciences will hold a meeting of the Board of Directors of the Company on 25 ...

Read more

19 Jul 202410:41

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Glenmark Life Sciences Ltd Quarterly Result

What is the EPS of Glenmark Life Sciences Ltd stock?

The Earnings Per Share (EPS) of Glenmark Life Sciences Ltd is 34.56. An EPS is the amount of net income attributed to each share of a common stock.

How is Glenmark Life Sciences Ltd EPS calculated?

The EPS of Glenmark Life Sciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Glenmark Life Sciences Ltd report its EPS?

Glenmark Life Sciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Glenmark Life Sciences Ltd EPS?

Factors that influence the EPS of Glenmark Life Sciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Glenmark Life Sciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Glenmark Life Sciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*